MayonRX provides clinical decision support by calibrating CYP450 catalytic chambers to enhance drug safety and pharmacology insights.
Why it matters
overview
MayonRX is a clinical decision support system tool developed by Infidos that enables healthcare professionals and pharmaceutical researchers to enhance drug safety and pharmacology insights. It calibrates CYP450 catalytic chambers to deliver rapid, precise drug interaction alerts based on patient-specific factors, adhering to FDA standards.
features
MayonRX incorporates several features designed to support clinical decision-making and drug safety, focusing on metabolic processes and regulatory compliance.
use cases
MayonRX is designed for professionals and organizations involved in drug development, prescription, and patient care, where precise pharmacological insights and drug safety are paramount.
how to use
Specific instructions for using MayonRX are not publicly detailed, but general usage would involve inputting patient data and drug information to receive interaction alerts and metabolic insights.
pricing
MayonRX operates on a freemium model, offering a free tier with unspecified features. Further details on paid tiers or advanced functionalities are not publicly available.
Enjoying this? Get one like it in your inbox each morning.
one email a day · unsubscribe in two clicks · no third-party tracking
Similar Tools
MayonRX competes in the pharmacogenomics and clinical decision support space with tools that offer varying approaches to drug interaction and metabolism analysis.
PharmCAT takes an individual's genetic data and determines drug-related genotypes and phenotypes, producing personalized reports with expert-reviewed drug prescribing recommendations.
While MayonRX emphasizes 'calibrating CYP450 catalytic chambers,' PharmCAT focuses on interpreting existing genetic data to assign phenotypes and provide actionable drug guidance based on established guidelines like CPIC. It requires local setup and technical expertise to run.
NeuroPGx is a browser-based R application that identifies diplotypes and metabolization phenotypes for selected CYP genes, providing information on neuropsychiatric drugs with recommended dosage adjustments.
NeuroPGx is specifically tailored for neuropsychiatric drug metabolism and requires an R environment to run, making it more niche and potentially less user-friendly for general clinical use compared to MayonRX's broader scope and potentially more polished interface.
PGxAI is a configurable clinical decision support platform that surfaces drug-drug interactions, contraindications, and pharmacogenomic guidance from FDA-required labeling and established sources for clinician review.
PGxAI focuses on providing evidence-linked guidance from FDA labeling and established sources, similar to MayonRX's adherence to FDA standards. However, it uses already-interpreted PGx results, whereas MayonRX implies a more direct 'calibration' of CYP450.
Abomics offers an API-first pharmacogenetic interpretation service that delivers secure, standards-based integration of PGx recommendations and patient-specific reports into clinical workflows.
Abomics provides a robust API for integrating pharmacogenomic insights, which is suitable for developers or systems requiring programmatic access, offering flexibility that MayonRX might provide through its own platform. It focuses on delivering interpreted PGx reports rather than direct 'CYP450 catalytic chamber calibration.'
More on Stork
Other tools in this category, matched by shared tags
One short daily email of tools worth shipping. No drip funnel.
one email a day · unsubscribe in two clicks · no third-party tracking
For builders
AI agents read it. Buyers land on it. It answers in eight languages and over MCP. Your tool can have one like it — live in 24 hours.
